Skip to main content
Julie Ducharme, MD, Endocrinology, Aberdeen, MD, University of Maryland Upper Chesapeake Medical Center

JulieL.DucharmeMD

Endocrinology • Aberdeen, MD

Diabetes, Osteoporosis & Bone Metabolism Medicine, Thyroid

Physician

Join to view full profile

Dr. Ducharme is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ducharme's full profile

Already have an account?

Education & Training

  • University of Maryland
    University of MarylandFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2007
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2002 - 2005
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2002

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2007 - 2024
  • PA State Medical License
    PA State Medical License 2002 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Imbrium Therapeutics Completes First Patient Visit in Phase 1 Study of Potential Treatment for Interstitial Cystitis/Bladder Pain Syndrome
    Imbrium Therapeutics Completes First Patient Visit in Phase 1 Study of Potential Treatment for Interstitial Cystitis/Bladder Pain SyndromeDecember 20th, 2022
  • Imbrium Therapeutics L.P. Exercising Option with PureTech Health to Develop and Commercialize a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome Treatment
    Imbrium Therapeutics L.P. Exercising Option with PureTech Health to Develop and Commercialize a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome TreatmentAugust 11th, 2021
  • FDA Approves Supplemental New Drug Application for Adhansia XR® (Methylphenidate HCl) Extended-Release Capsules CII
    FDA Approves Supplemental New Drug Application for Adhansia XR® (Methylphenidate HCl) Extended-Release Capsules CIIJuly 1st, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • French

Hospital Affiliations

Dr. Julie Ducharme, Dr. Julie Ducharme, MD, Dr. J Ducharme, Dr. Julie L. Ducharme